Chachlaki K, Garthwaite J, Prevot V
The bulk of clinical evidence about BBB breakdown is derived from postmortem human brain tissue analyses, which inherently limits our ability to assess real-time dysfunction or track disease progression [27, 309]
Twice daily application is usually unnecessary, the enhanced permeability means you're getting adequate penetration from single application
In 1907 Alois Alzheimer described the symptoms presented by a 51-year old woman, Auguste Deter
The research is strongest in soft-tissue repair and gastrointestinal protection models, with evidence showing benefit in tendon healing, ligament repair, muscle injury, wound healing, angiogenesis, inflammatory modulation, and gut mucosal protection